Genetic models to study chemokine biology in the lung

Sergio A. Lira, Galya Vassileva, Shu Cheng Chen, Nicholas W. Lukacs, Stephen W. Chensue, Theodore J. Standiford, Borna Mehrad, Donald N. Cook

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Leukocyte migration from the blood to peripheral tissue is important for the clearance of infectious pathogens, but it is also a major component of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. An improved understanding of the molecular events underlying leukocyte migration in vivo would aid in the design of novel strategies to intervene therapeutically in these and other diseases. In recent years, much interest has focused on the possibility of using antagonists of chemokine function to block leukocyte migration in vivo. This interest has stemmed from two basic observations. First, chemokines have been long-known to induce directed migration of leukocytes in vivo. Second, many chemokine genes are highly expressed at sites of inflammation. To directly test the hypothesis that this expression is of functional importance to leukocyte migration in vivo, some investigators have conducted chemokine gain-of-function and loss-of-function experiments using genetically modified mice (1). In this chapter, we summanze recent genetic experiments, from our laboratories, that have revealed important roles for chemokme function in vivo, with a particular emphasis on chemokme function in the lung We will review our work on the CXC chemokines KC and lungkine, as well as our work on the chemokme receptors CCR6 and CCR8.

Original languageEnglish
Title of host publicationChemokines in the Lung
PublisherCRC Press
Number of pages15
ISBN (Electronic)9780824747442
ISBN (Print)9780824708580
StatePublished - 1 Jan 2003
Externally publishedYes


Dive into the research topics of 'Genetic models to study chemokine biology in the lung'. Together they form a unique fingerprint.

Cite this